EDGE PharmaTech SRL
The score of EDGE PharmaTech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -94 % Total assets -34 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
EDGE PharmaTech's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Mar 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 03 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
EDGE PharmaTech's financial analysis
- Solvency8.1%sector median: 49.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of EDGE PharmaTech
EDGE PharmaTech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0753.817.088
- VAT number
- BE0753817088
- Peppol
- Registered · 0208:0753817088 · as of 04 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Sep 2020
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 02 Mar 2026
- Activity
- Engineering activities and technical consultancy, except activities of land surveyors (NACE 71121)
EDGE PharmaTech (SRL) has been based in Uccle since 2020, active in: engineering activities and technical consultancy, except activities of land surveyors. For 2025, it reports a net profit of 62,813 € and equity of 7,813 €; its revenue is not published. Its solvency stands at 8.1%, below the median of its sector (49.7%).
Companies similar to EDGE PharmaTech
Companies in the same business, of comparable size and area, outside its group.
- BELZ Engineering activities and related technical consultancy Asse · balance sheet 126,253 €
- OUT OF Scope Engineering activities and related technical consultancy Ixelles · balance sheet 68,201 €
- Ematics Engineering activities and related technical consultancy Genappe · balance sheet 51,883 €
- Isabel Lillywhite Engineering activities and related technical consultancy Braine-l'Alleud · balance sheet 104,708 €
- KLDM Consulting Engineering activities and related technical consultancy Ixelles · balance sheet 62,269 €
- YIVA Engineering Engineering activities and related technical consultancy Braine-l'Alleud · balance sheet 105,055 €
- Slimtec Engineering activities and related technical consultancy Uccle · balance sheet 87,638 €
- Hoek Bioprocess Engineering Engineering activities and related technical consultancy Jette · balance sheet 36,569 €
Frequently asked questions about EDGE PharmaTech
What is the revenue of EDGE PharmaTech?
EDGE PharmaTech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of EDGE PharmaTech?
In Belgium, the VAT number is the company number prefixed with BE: BE0753817088 for EDGE PharmaTech, if the company is VAT-registered. Its company number (CBE) is 0753.817.088.
Where is the registered office of EDGE PharmaTech?
According to the CBE register, the registered office of EDGE PharmaTech is in 1180 Uccle.
What is the equity of EDGE PharmaTech?
At the close of the 2025 financial year, the equity of EDGE PharmaTech amounts to 7,813 €, a solvency of 8.1% of total assets.
Who manages EDGE PharmaTech?
The register lists 1 active mandates at EDGE PharmaTech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of EDGE PharmaTech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →